Harnessing nanozymes as next-generation antimicrobial agents: From mechanisms to therapeutic strategies
Materials Today Bio · 2025-12 · 35 · 102499
DOI: 10.1016/j.mtbio.2025.102499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2025-12. Verfasst von Shanshan Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center for Pharmaceuticals and Equipments of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, …. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The escalating threat of antimicrobial resistance (AMR) and the limited efficacy of conventional antibiotics have intensified the search for alternative therapeutic strategies. Nanozymes, nanomaterials with enzyme-mimicking properties, have emerged as a promising class of antimicrobial agents due to their broad-spectrum activity, tunable catalytic functions, and resistance-independent mechanisms. This review provides a comprehensive overview of the recent advances in nanozyme-based antimicrobial applications, focusing on their classification, catalytic mechanisms, and multifaceted antimicrobial actions. We highlight the unique advantages of nanozymes, including their ability to generate reactive oxygen species (ROS), disrupt biofilms, modulate infection microenvironments, and synergize with other therapeutic modalities. Furthermore, we discuss their performance in various infection models, such as skin and soft tissue infections, oral infections, ocular infections, gastrointestinal infections, respiratory infections, urinary tract infections, systemic infections, diabetic wounds, chronic ulcers, and fungal infections. Finally, we address current challenges in clinical translation, including biosafety, dose control, and scalable production. This review underscores the transformative potential of nanozymes in combating drug-resistant pathogens and offers insights into future directions for their clinical development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Engineering Research Center for Pharmaceuticals and Equipments of Sichuan Province, Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, 610106, China.
- Infectious diseases Department, Traditional Chinese Medicine Hospital of Meishan, Meishan, 620020, China.
- Traditional Chinese Medicine Hospital of Meishan, Meishan, 620020, China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, China.
Zitieren
APA
Feng, S., Wang, Z., Zhang, Y., Mei, L., & Wang, Z. (2025). Harnessing nanozymes as next-generation antimicrobial agents: From mechanisms to therapeutic strategies. Materials Today Bio, 35, 102499. https://doi.org/10.1016/j.mtbio.2025.102499
Vancouver
Feng S, Wang Z, Zhang Y, Mei L, Wang Z. Harnessing nanozymes as next-generation antimicrobial agents: From mechanisms to therapeutic strategies. Materials Today Bio. 2025;35:102499. doi:10.1016/j.mtbio.2025.102499
BibTeX
@article{Feng2025,
author = {Feng, Shanshan and Wang, Zhaoxun and Zhang, Yibin and Mei, Ling and Wang, Zhenxing},
title = {Harnessing nanozymes as next-generation antimicrobial agents: From mechanisms to therapeutic strategies},
journal = {Materials Today Bio},
year = {2025},
volume = {35},
pages = {102499},
doi = {10.1016/j.mtbio.2025.102499}
}
EUVIMED